• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume10, Issue4

WARM ISCHEMIA TIME IN ROBOTIC DONOR NEPHRECTOMY (LIVING) VS OPEN DONOR NEPHRECTOMY (LIVING) AND OUTCOME

    Dr. Vinay Mahendra, Dr. Palash Saha, Dr. Joy Bhadra Roy, Dr. Tridibesh Mandal, Dr. Swati Khatri

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 4, Pages 1103-1107

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Kindly transplant is the most valuable surgery to improve the survival and change in life style quality in the end stage of renal dises in living robotic donor nephrectomy reduces waiting time for resipent patient and avoid more Hemodialysis.
Aims: The aim of the study is to analyze the effect of graft kidney short and long time outcome. After Robotic living donor nephrectomy with minimal hospital stay.
Materials and Methods: This study conducted on patient admitted for renal transplant both the donor and resipent posted for OT for living robotic donor nephrectomy and also posted for open donor nephrectomy in Apollo malty specialty Hospital Kolkata all patient were older than 20 years both the donor and resipent in the study analysis of robotic donor nephrectomy of warm ischemia time on delayed graft function rate of decline in in serum creatinine in the first 10 days and change of creatinine at 3 month Acute and delayed graft rejection.
Result: It nephrectomy Robotic (Living) is a safe procedure immediate kidney allograft function was good with less chance injury in graft kidney, vein, artery, ureter it was performed successfully in all case with a short surgical time with also low morbidity and 0% moriality and minimal hospital stay very less chance in acute and delayed graft kidney rejection with grate cosmetic value.
Conclusion: In our study we found that, In nephrectomy Robotic (Living) was better procedure than open donor nephrectomy (Living).
Keywords:
    kidney transplantation living donor nephrectomy minimally and robotics
  • PDF (280 K)
  • XML
(2023). WARM ISCHEMIA TIME IN ROBOTIC DONOR NEPHRECTOMY (LIVING) VS OPEN DONOR NEPHRECTOMY (LIVING) AND OUTCOME. European Journal of Molecular & Clinical Medicine, 10(4), 1103-1107.
Dr. Vinay Mahendra, Dr. Palash Saha, Dr. Joy Bhadra Roy, Dr. Tridibesh Mandal, Dr. Swati Khatri. "WARM ISCHEMIA TIME IN ROBOTIC DONOR NEPHRECTOMY (LIVING) VS OPEN DONOR NEPHRECTOMY (LIVING) AND OUTCOME". European Journal of Molecular & Clinical Medicine, 10, 4, 2023, 1103-1107.
(2023). 'WARM ISCHEMIA TIME IN ROBOTIC DONOR NEPHRECTOMY (LIVING) VS OPEN DONOR NEPHRECTOMY (LIVING) AND OUTCOME', European Journal of Molecular & Clinical Medicine, 10(4), pp. 1103-1107.
WARM ISCHEMIA TIME IN ROBOTIC DONOR NEPHRECTOMY (LIVING) VS OPEN DONOR NEPHRECTOMY (LIVING) AND OUTCOME. European Journal of Molecular & Clinical Medicine, 2023; 10(4): 1103-1107.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 14
  • PDF Download: 18
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus